Glazer Capital LLC’s Checkpoint Therapeutics CKPT Stock Holding History

Glazer Capital LLC’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,165,000	Closed	-$12.8M	–	246
2025 Q1	$12.8M	Buy	+3,165,000	New	+$10.5M	0.59%	37

Glazer Capital LLC's CKPT Position: Q2 2025 in Review

Glazer Capital LLC sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 3,165,000 shares — an estimated $12.8M sold.

Glazer Capital LLC first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $12.8M in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Glazer Capital LLC reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Glazer Capital LLC sold 3,165,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $12.8M.
Glazer Capital LLC first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Glazer Capital LLC's Checkpoint Therapeutics position peaked at $12.8M in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Glazer Capital LLC's 13F filing for Q2 2025, filed 14 Aug 2025.